Results 131 to 140 of about 10,942 (165)

Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistence. [PDF]

Hematol Transfus Cell Ther
Cançado RD, de Melo Campos P, Kashiura D, Thies F, Ferreira E, de Almeida ABM, Leonel LP, Cortez LV, Melo N, Fedozzi F, Bigoni A.   +10 more
europepmc   +1 more source

A novel homozygous <i>ARFGEF2</i> splice-site variant causing periventricular nodular heterotopia with microcephaly. [PDF]

Front Pediatr
Liu X, Pang L, Li J, Zhang J, Wu W, Li X, Gong Y, Dou Y, Chen F, Sun S.   +9 more
europepmc   +1 more source

Ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria during pregnancy. [PDF]

Blood Adv
Höchsmann B, Gerber GF, Leopold W, Patel BJ, Gavriilaki E, Hefter A, Kalhammer U, Opitz S, Marx-Hoffmann A, Knight DB, Brodsky RA, Marvaki A, Lalayanni C, Körper S, Babushok DV, Schrezenmeier H.   +15 more
europepmc   +1 more source

Acute Pancreatitis as a Therapeutic Complication in Case of Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Ann Afr Med
Reddy MSR, Dhere IA, Edara M, Reddy KSA.
europepmc   +1 more source

Efficacy and Safety of Crovalimab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Meta-Analysis. [PDF]

EJHaem
Javaid H, Qadri M, Ali H, Chilaka CF, Syed W, Habib E, Zahin F, Musani A, Khan SA, Rizwan D, Saddique MN, Hajj F.   +11 more
europepmc   +1 more source

Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment. [PDF]

J Comp Eff Res
Kulasekararaj A, Scheinberg P, Balp MM, Somenzi O, Wiyani A, Snellman J, Walsh S, Pannagl K, Steenkamp J, de Latour RP.   +9 more
europepmc   +1 more source

Acute Kidney Injury, Fever, and Dark Urine in a Kidney Transplant Recipient. [PDF]

Kidney360
Rosenstiel PE, Goyal A.
europepmc   +1 more source

Direct Switch From Iptacopan to Pegcetacoplan in a Patient With Paroxysmal Nocturnal Hemoglobinuria. [PDF]

EJHaem
Latyshev V, Fidarova Z, Lukina E, Parovichnikova E.   +3 more
europepmc   +1 more source

Shifting From Systemic to Precision-Targeted Complement Therapies: Opportunities and Hurdles. [PDF]

Eur J Immunol
Mannes M, Zelek WM, Trouw LA.
europepmc   +1 more source

Optimizing Care in Patients with Paroxysmal Nocturnal Hemoglobinuria: Managing Suboptimal Response and Uncontrolled Disease. [PDF]

J Blood Med
Bienz M, Oliver M, Sperlich C, Patriquin CJ.   +3 more
europepmc   +1 more source